146
Rebound hyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins , and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat .
 adverse effect: Rebound hyperglycemia, protamine hagedorn; adverse effect: Rebound hyperglycemia, protamine zinc iletin
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  Rebound hyperglycemia, protamine hagedorn; Rebound hyperglycemia, protamine zinc iletin 
Answer:
 adverse effect: Rebound hyperglycemia, protamine hagedorn; adverse effect: Rebound hyperglycemia, protamine zinc iletin